1. A Cost‐Effectiveness Analysis of Nivolumab and Ipilimumab Versus Sunitinib in First‐Line Intermediate‐ to Poor‐Risk Advanced Renal Cell Carcinoma. (1st February 2019) Authors: Reinhorn, Daniel; Sarfaty, Michal; Leshno, Moshe; Moore, Assaf; Neiman, Victoria; Rosenbaum, Eli; Goldstein, Daniel A. Journal: Oncologist Issue: Volume 24:Number 3(2019) Page Start: 366 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Alternative nivolumab duration and scheduling in advanced nonsmall cell lung cancer: A real‐world evidence. Issue 5 (16th September 2020) Authors: Dudnik, Elizabeth; Moskovitz, Mor; Agbarya, Abed; Gottfried, Teodor; Shochat, Tzippy; Urban, Damien; Zer, Alona; Rotem, Ofer; Moore, Assaf; Yust, Shlomit; Peled, Nir; Wollner, Mira; Bar, Jair Journal: International journal of cancer Issue: Volume 148:Issue 5(2021) Page Start: 1183 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Early PET‐CT in patients with pathological stage III colon cancer may improve their outcome: Results from a large retrospective study. (22nd October 2018) Authors: Moore, Assaf; Ulitsky, Olga; Ben‐Aharon, Irit; Perl, Gali; Kundel, Yulia; Sarfaty, Michal; Lewin, Ron; Domachevsky, Liran; Bernstine, Hanna; Groshar, David; Wasserberg, Nir; Kashtan, Hanoch; Gordon, Noa; Sulkes, Aaron; Brenner, Baruch Journal: Cancer medicine Issue: Volume 7:Number 11(2018:Nov.) Page Start: 5470 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy of immune check-point inhibitors (ICPi) in large cell neuroendocrine tumors of lung (LCNEC). (May 2020) Authors: Sherman, Shira; Rotem, Ofer; Shochat, Tzippy; Zer, Alona; Moore, Assaf; Dudnik, Elizabeth Journal: Lung cancer Issue: Volume 143(2020) Page Start: 40 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis. (1st September 2020) Authors: Kundel, Yulia; Sternschuss, Michal; Moore, Assaf; Perl, Gali; Brenner, Baruch; Goldvaser, Hadar Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Efficacy of immune‐checkpoint inhibitors in metastatic gastric or gastroesophageal junction adenocarcinoma by patient subgroups: A systematic review and meta‐analysis. (1st September 2020) Authors: Kundel, Yulia; Sternschuss, Michal; Moore, Assaf; Perl, Gali; Brenner, Baruch; Goldvaser, Hadar Journal: Cancer medicine Issue: Volume 9:Number 20(2020) Page Start: 7613 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Fractionation scheme and treatment planning method for early glottic cancer in the United States: Economic impact of different medical decisions. Issue 8 (24th January 2020) Authors: Moore, Assaf; Den, Robert B.; Popovtzer, Aaron; Goldvaser, Hadar; Gordon, Noa; Goldstein, Daniel A. Journal: Head & neck Issue: Volume 42:Issue 8(2020) Page Start: 1713 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Induction chemotherapy for locally advanced laryngeal and hypopharyngeal cancer: Single institution experience. Issue 11 (16th July 2020) Authors: Dagan, Or; Moore, Assaf; Nachalon, Yuval; Alkan, Uri; Biadsee, Ameen; Shochat, Isaac; Popovtzer, Aron Journal: Head & neck Issue: Volume 42:Issue 11(2020) Page Start: 3118 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Locoregional therapy in de novo metastatic breast cancer: Systemic review and meta-analysis. (August 2021) Authors: Reinhorn, Daniel; Mutai, Raz; Yerushalmi, Rinat; Moore, Assaf; Amir, Eitan; Goldvaser, Hadar Journal: Breast Issue: Volume 58(2021) Page Start: 173 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. National comprehensive cancer network recommendations for drugs without US food and drug administration approval in metastatic breast cancer: A cross-sectional study. (December 2020) Authors: Etan, Tal; Amir, Eitan; Tibau, Ariadna; Yerushalmi, Rinat; Moore, Assaf; Shepshelovich, Daniel; Goldvaser, Hadar Journal: Cancer treatment reviews Issue: Volume 91(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗